Lotus Eye Hospital and Institute Limited Stock Price Today (NSE: LOTUSEYE)

Lotus Eye Hospital and Institute Limited

LOTUSEYEHospital
₹114.36+₹4.96 (+4.53%)
Market Closed

Fundamental Score

...

Lotus Eye Hospital and Institute Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Lotus Eye Hospital and Institute Limited share price today is ₹114.36, up +4.53% on NSE/BSE as of 16 October 2026. Lotus Eye Hospital and Institute Limited (LOTUSEYE) is a Small-cap company in the Hospital sector with a market capitalisation of ₹237.83 (Cr). The 52-week high for LOTUSEYE share price is ₹147.00 and the 52-week low is ₹97.59. At a P/E ratio of 1429.50x, LOTUSEYE is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 0.13% and a debt-to-equity ratio of 0.19.

Lotus Eye Hospital and Institute Limited Share Price Chart — NSE/BSE Historical Performance

Lotus Eye Hospital and Institute Limited share price chart: -0.50% return over the past month. 52-week high ₹147.00, 52-week low ₹97.59.

Lotus Eye Hospital and Institute Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
₹111.59₹115.40₹111.10₹114.367.21K (Cr)
₹112.97₹114.00₹109.00₹109.4056.52K (Cr)
₹108.00₹113.50₹108.00₹111.8515.63K (Cr)
₹108.50₹116.00₹106.50₹110.5584.89K (Cr)
₹115.00₹115.00₹106.00₹107.1345.10K (Cr)
₹115.07₹115.49₹113.06₹113.935.87K (Cr)
₹116.60₹116.60₹113.61₹113.942.26K (Cr)
₹115.00₹116.89₹114.10₹114.843.25K (Cr)
₹114.85₹115.80₹114.85₹115.3712.51K (Cr)
₹116.00₹117.90₹114.60₹115.613.54K (Cr)

Lotus Eye Hospital and Institute Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
₹116.60₹117.90₹106.00₹114.36-1.92%
₹110.42₹117.73₹105.00₹115.89+4.95%
₹122.00₹122.00₹107.60₹109.08-10.59%
₹116.82₹131.98₹115.46₹117.51+0.59%
₹106.30₹143.20₹106.30₹116.82+9.90%
₹117.55₹121.06₹101.02₹108.57-7.64%
₹99.01₹129.79₹99.01₹118.87+20.06%
₹109.48₹113.07₹97.59₹98.22-10.28%
₹127.00₹136.71₹106.01₹110.19-13.24%
₹119.58₹147.00₹104.50₹135.27+13.12%
₹103.61₹138.00₹101.50₹119.24+15.09%
₹127.00₹133.00₹102.11₹105.65-16.81%

Returns & Performance

Poor

Return on Equity (ROE)

0.13%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

1.19%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

13.22%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Lotus Eye Hospital and Institute Limited Valuation Check

Poor

Price to Earnings (P/E)

1429.50x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

48.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

40.14%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.02%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

87.15%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

12.65%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

26.19%

Revenue growth vs same quarter last year

Average

Revenue Growth (5-Year CAGR)

10.66%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-39.90%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-44.79%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.19x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

0.94x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-10.98 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Lotus Eye Hospital and Institute Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of LOTUSEYE across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Strong Revenue Growth (26.19%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.19)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Risk Factors

10 factors identified

Below-Average Return on Equity (0.13%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (1.19%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 1429.50x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Weak Earnings Growth (-39.90% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-44.79% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Weak Interest Coverage (0.94x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-10.98 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.02%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

High Share Pledging Risk (87.15%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Lotus Eye Hospital and Institute Limited vs Hospital Peers

Peer Comparison - Hospital

Compare Lotus Eye Hospital and Institute Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
29.4/100
₹114
₹237.83
1429.5
Average
0.13%
Poor
1.19%
Poor
0.2
Excellent
-44.79%
Poor
10.66%
Good
0.00%
64.1/100
₹7890
₹113458.20
54.3
Average
21.95%
Excellent
19.28%
Good
0.6
Good
66.81%
Excellent
19.03%
Excellent
0.22%
55.5/100
₹846
₹82336.10
56.4
Average
14.33%
Average
13.43%
Average
0.3
Excellent
60.01%
Excellent
27.30%
Excellent
0.18%
50.6/100
₹737
₹55602.80
53.1
Average
11.08%
Average
12.83%
Average
0.3
Excellent
64.38%
Excellent
17.76%
Excellent
0.10%
65.7/100
₹1719
₹35137.83
42.8
Average
19.74%
Good
14.53%
Average
1.1
Average
155.30%
Excellent
25.05%
Excellent
0.22%
49.5/100
₹674
₹34940.10
109.1
Average
9.70%
Poor
11.35%
Average
0.2
Excellent
21.31%
Excellent
-11.61%
Poor
0.61%
57.9/100
₹1240
₹33327.48
59.9
Average
15.15%
Good
16.85%
Good
0.3
Excellent
80.71%
Excellent
24.97%
Excellent
0.04%
27.7/100
₹686
₹28795.20
134.4
Average
11.01%
Average
9.35%
Poor
1.4
Average
3.71%
Average
24.04%
Excellent
0.00%
57.3/100
₹466
₹14765.86
99.3
Average
6.84%
Poor
10.16%
Average
0.1
Excellent
34.42%
Excellent
34.58%
Excellent
0.00%
73/100
₹1249
₹12684.58
44.4
Average
17.86%
Good
18.10%
Good
0.0
Excellent
44.04%
Excellent
21.24%
Excellent
0.23%
66.1/100
₹992
₹9559.28
52.8
Average
9.98%
Poor
12.29%
Average
0.1
Excellent
57.39%
Excellent
41.18%
Excellent
0.00%

Lotus Eye Hospital and Institute Limited PE Ratio History

Historical price-to-earnings ratio for LOTUSEYE — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 2024₹1.40₹66.6447.6x
FY 2023₹1.96₹83.4042.6x
FY 2022₹1.44₹76.5553.2x
FY 2021₹0.75₹51.9069.2x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Lotus Eye Hospital and Institute Limited Dividend History

Annual cash dividends paid by LOTUSEYE — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 2025₹0.01 Cr
FY 2024₹1.01 Cr
FY 2023₹1.04 Cr
FY 2022₹1.03 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Lotus Eye Hospital and Institute Limited Quarterly Performance

Latest quarterly metrics for LOTUSEYE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

26.19%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

12.65%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

10.66%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-44.79%

Compounded annual net profit growth over 5 years

Lotus Eye Hospital and Institute Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for LOTUSEYE — calculated from daily price history

49RSI 14
Neutral — RSI 49

Momentum is balanced — neither overbought nor oversold.

SMA 50
₹114
▲ Price above SMA 50 — Short-term bullish
SMA 200
₹116
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
13K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Lotus Eye Hospital and Institute Limited Financial Statements

Annual income statement, balance sheet and cash flow for Lotus Eye Hospital and Institute Limited (LOTUSEYE) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Lotus Eye Hospital and Institute Limited

Loading latest quarterly results...

About LOTUSEYE (Lotus Eye Hospital and Institute Limited)

Lotus Eye Hospital and Institute Ltd is a beacon of ophthalmic excellence, dedicated to preserving and enhancing vision through cutting-edge technology and compassionate care. Our ...state-of-the-art facilities house a comprehensive range of diagnostic and surgical equipment, enabling our team of highly skilled ophthalmologists to provide tailored treatments for a wide spectrum of eye conditions. From the subtle nuances of refractive errors to the complexities of retinal diseases, we approach each patient with a personalized strategy, prioritizing precision and optimal outcomes. We strive to create a comfortable and supportive environment, ensuring that every individual feels informed, empowered, and confident in their journey towards improved vision. Our commitment extends beyond clinical expertise to encompass a deep understanding of the emotional and psychological impact of vision impairment, fostering a holistic approach to eye care. Our hospital is renowned for its pioneering advancements in refractive surgery, offering a suite of sophisticated procedures designed to correct vision without the need for glasses or contact lenses. We utilize advanced techniques such as Femto LASIK, Contoura Vision, and ReLEx SMILE, tailoring each procedure to the unique characteristics of the patient's eye. In addition to refractive surgery, we specialize in the diagnosis and treatment of cataracts, glaucoma, and other vision-threatening conditions. Our surgeons are proficient in performing minimally invasive cataract surgery using advanced phacoemulsification and femtosecond laser technology. We provide comprehensive glaucoma management, utilizing the latest diagnostic tools and treatment modalities to preserve visual function and prevent further damage. Furthermore, Lotus Eye Hospital and Institute Ltd is committed to providing specialized care for children with eye disorders. Our pediatric ophthalmologists possess expertise in diagnosing and treating conditions such as strabismus (squint), amblyopia (lazy eye), and congenital cataracts. We understand the unique challenges of pediatric eye care and create a welcoming and child-friendly environment to ensure that young patients feel comfortable and at ease. Our institute is also dedicated to research and education, contributing to the advancement of ophthalmic knowledge and training the next generation of eye care professionals. We aim to be a center of excellence, continuously innovating and improving our services to provide the highest quality eye care to the community.

Company Details

Symbol:LOTUSEYE
Industry:Hospital
Sector:Hospital

Key Leadership

Ms. Sangeetha Sundaramoorthy
MD & Director
Mr. Ramanujam Reghunathan
Chief Financial Officer
Mr. Mohanmenon Achuth Menon
Company Secretary & Compliance Officer

LOTUSEYE Share Price: Frequently Asked Questions

What is the current share price of Lotus Eye Hospital and Institute Limited?

Lotus Eye Hospital and Institute Limited (LOTUSEYE) trades at ₹114.36 on NSE and BSE. Market cap ₹237.83 (Cr). Educational data only.

What is the P/E ratio of Lotus Eye Hospital and Institute Limited?

Lotus Eye Hospital and Institute Limited has a P/E of 1429.50x vs industry average 48.79x.

What is the Bull Run score for Lotus Eye Hospital and Institute Limited?

Lotus Eye Hospital and Institute Limited has a Bull Run score of 29.4/100 based on 25+ financial parameters.

Does Lotus Eye Hospital and Institute Limited pay dividends?

Lotus Eye Hospital and Institute Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Lotus Eye Hospital and Institute Limited?

Lotus Eye Hospital and Institute Limited has ROE of 0.13%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Lotus Eye Hospital and Institute Limited?

Lotus Eye Hospital and Institute Limited has debt-to-equity of 0.19.

Is Lotus Eye Hospital and Institute Limited a good investment?

Bull Run gives Lotus Eye Hospital and Institute Limited a score of 29.4/100. This is not investment advice — consult a SEBI-registered advisor.